InspireMD Statistics
Total Valuation
InspireMD has a market cap or net worth of $71.07 million. The enterprise value is $38.78 million.
Important Dates
The next confirmed earnings date is Friday, May 9, 2025, before market open.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
InspireMD has 30.64 million shares outstanding. The number of shares has increased by 72.77% in one year.
| Current Share Class | 30.64M |
| Shares Outstanding | 30.64M |
| Shares Change (YoY) | +72.77% |
| Shares Change (QoQ) | +1.08% |
| Owned by Insiders (%) | 23.76% |
| Owned by Institutions (%) | 24.22% |
| Float | 17.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.88 |
| Forward PS | 7.34 |
| PB Ratio | 1.71 |
| P/TBV Ratio | 1.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.28, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.28 |
| Quick Ratio | 4.80 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -84.68% and return on invested capital (ROIC) is -52.66%.
| Return on Equity (ROE) | -84.68% |
| Return on Assets (ROA) | -44.34% |
| Return on Invested Capital (ROIC) | -52.66% |
| Return on Capital Employed (ROCE) | -85.62% |
| Revenue Per Employee | $81,500 |
| Profits Per Employee | -$372,151 |
| Employee Count | 86 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 2.35 |
Taxes
In the past 12 months, InspireMD has paid $59,000 in taxes.
| Income Tax | 59,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.00% in the last 52 weeks. The beta is 0.74, so InspireMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +16.00% |
| 50-Day Moving Average | 2.80 |
| 200-Day Moving Average | 2.74 |
| Relative Strength Index (RSI) | 32.95 |
| Average Volume (20 Days) | 39,048 |
Short Selling Information
The latest short interest is 191,929, so 0.63% of the outstanding shares have been sold short.
| Short Interest | 191,929 |
| Short Previous Month | 240,060 |
| Short % of Shares Out | 0.63% |
| Short % of Float | 1.10% |
| Short Ratio (days to cover) | 3.70 |
Income Statement
In the last 12 months, InspireMD had revenue of $7.01 million and -$32.01 million in losses. Loss per share was -$0.76.
| Revenue | 7.01M |
| Gross Profit | 1.51M |
| Operating Income | -33.50M |
| Pretax Income | -25.46M |
| Net Income | -32.01M |
| EBITDA | -33.22M |
| EBIT | -33.50M |
| Loss Per Share | -$0.76 |
Full Income StatementBalance Sheet
The company has $34.64 million in cash and $2.34 million in debt, giving a net cash position of $32.30 million or $1.05 per share.
| Cash & Cash Equivalents | 34.64M |
| Total Debt | 2.34M |
| Net Cash | 32.30M |
| Net Cash Per Share | $1.05 |
| Equity (Book Value) | 36.09M |
| Book Value Per Share | 1.36 |
| Working Capital | 32.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$21.87 million and capital expenditures -$1.40 million, giving a free cash flow of -$23.27 million.
| Operating Cash Flow | -21.87M |
| Capital Expenditures | -1.40M |
| Free Cash Flow | -23.27M |
| FCF Per Share | -$0.76 |
Full Cash Flow StatementMargins
| Gross Margin | 21.49% |
| Operating Margin | -478.00% |
| Pretax Margin | -455.79% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InspireMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -72.77% |
| Shareholder Yield | -72.77% |
| Earnings Yield | -45.03% |
| FCF Yield | -32.74% |
Analyst Forecast
The average price target for InspireMD is $4.75, which is 104.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.75 |
| Price Target Difference | 104.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on April 27, 2021. It was a reverse split with a ratio of 0.0666666667:1.
| Last Split Date | Apr 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.0666666667:1 |
Scores
InspireMD has an Altman Z-Score of -5.38 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.38 |
| Piotroski F-Score | 1 |